Product Code: SR112025A5912
The global blood bags market size reached USD 312.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 637.2 Million by 2033, exhibiting a growth rate (CAGR) of 7.38% during 2025-2033. The market is experiencing moderate growth driven by the rising demand for blood transfusions, various technological advancements, the expanding healthcare infrastructure in emerging markets, stringent regulatory compliance, and the growing awareness about blood donation.
A blood bank is a facility where blood is collected from donors, typed, separated into components, stored, and prepared for transfusion to patients. The blood is separated into red blood cells (RBCs), plasma, and platelets, which are transfused to different individuals according to their requirements. Blood banks avoid transfusion-related reactions by providing proper identification of the patients and blood products. In addition, they offer distribution services of blood to hospitals, ambulatory surgery centers, pharmaceutical companies, and research centers.
Blood Bank Market Trends:
The growing prevalence of hematological diseases, such as rare genetic conditions, anemia, and sickle cell disease due to disorders of the blood and blood-forming organs, represents one of the key factors driving the market. Moreover, there is an increase in the demand for safe blood due to the rising cases of transfusion transmissible infections (TTI), such as human immunodeficiency viruses (HIV) and hepatitis B. This, along with the increasing geriatric population across the globe, is propelling the growth of the market. In addition, there is a rise in the demand for red blood cells (RBCs) in amputation surgeries. This, coupled with various benefits associated with red blood cells (RBCs), such as easy availability and low cost of storage and maintenance, is positively influencing the market. Besides this, governments of several countries are taking initiatives to promote blood donation around the world. In line with this, the expanding healthcare industry is offering lucrative growth opportunities to end-users and investors. Additionally, the rising number of accidents in sports due to poor training methods, structural abnormalities, and unsafe exercising environments is bolstering the demand for packed red blood cells (RBCs) during blood transfusions.
Key Market Segmentation:
Breakup by Product Type:
- Whole Blood
- Red Blood Cells
- Platelet
- Plasma
- White Blood Cells
Breakup by Bank Type:
Breakup by Function:
- Collection
- Processing
- Testing
- Storage
- Transportation
Breakup by End User:
- Hospital
- Ambulatory Surgery Centers
- Pharmaceutical Companies
- Clinics and Nursing Homes
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being American Association of Blood Banks, Blood Bank of Alaska, Canadian Blood Services, Haemonetics Corporation, Japanese Red Cross Society, New York Blood Center, NHS Blood and Transplant, Sanquin Bloedvoorziening, Terumo Corporation, The American National Red Cross and Vitalant.
Key Questions Answered in This Report
- 1.What was the size of the global blood bags market in 2024?
- 2.What is the expected growth rate of the global blood bags market during 2025-2033?
- 3.What are the key factors driving the global blood bags market?
- 4.What has been the impact of COVID-19 on the global blood bags market?
- 5.What is the breakup of the global blood bags market based on the product type?
- 6.What is the breakup of the global blood bags market based on the application?
- 7.What is the breakup of the global blood bags market based on the end user?
- 8.What is the breakup of the global blood bags market based on the material?
- 9.What is the breakup of the global blood bags market based on the capacity?
- 10.What are the key regions in the global blood bags market?
- 11.Who are the key players/companies in the global blood bags market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Blood Bags Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Single Blood Bag
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Double Blood Bag
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Triple Blood Bag
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Quadruple Blood Bag
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Penta Blood Bag
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Collection Blood Bag
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Transfer Blood Bag
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Blood Banks
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Material
- 9.1 Poly Vinyl Chloride Blood Bag
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Polyethylene Terephthalate Blood Bag
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Capacity
- 10.1 100ml Blood Bag
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 150ml Blood Bag
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 250ml Blood Bag
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 300ml Blood Bag
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
- 10.5 350ml Blood Bag
- 10.5.1 Market Trends
- 10.5.2 Market Forecast
- 10.6 400ml Blood Bag
- 10.6.1 Market Trends
- 10.6.2 Market Forecast
- 10.7 450ml Blood Bag
- 10.7.1 Market Trends
- 10.7.2 Market Forecast
- 10.8 500ml Blood Bag
- 10.8.1 Market Trends
- 10.8.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.2 Europe
- 11.2.1 Germany
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 France
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 United Kingdom
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 Italy
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Spain
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Russia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.3 Asia Pacific
- 11.3.1 China
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 Japan
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 India
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 South Korea
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Australia
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Singapore
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Argentina
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.4 Others
- 11.4.4.1 Market Trends
- 11.4.4.2 Market Forecast
- 11.5 Middle East and Africa
- 11.5.1 Turkey
- 11.5.1.1 Market Trends
- 11.5.1.2 Market Forecast
- 11.5.2 South Africa
- 11.5.2.1 Market Trends
- 11.5.2.2 Market Forecast
- 11.5.3 Saudi Arabia
- 11.5.3.1 Market Trends
- 11.5.3.2 Market Forecast
- 11.5.4 UAE
- 11.5.4.1 Market Trends
- 11.5.4.2 Market Forecast
- 11.5.5 Others
- 11.5.5.1 Market Trends
- 11.5.5.2 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
- 15.1 Key Price Indicators
- 15.2 Price Structure
- 15.3 Price Trends
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 AdvaCare Pharma
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.2 BL Life Sciences Pvt. Ltd
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.3 Demophorius Healthcare Ltd.
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.4 Fresenius SE & Co. KGaA
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.4.4 SWOT Analysis
- 16.3.5 Grifols S.A.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 Haemonetics Corporation
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.6.4 SWOT Analysis
- 16.3.7 HLL Lifecare Limited
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.8 Innvol Medical India Limited
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.9 JMS Co. Ltd.
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.10 Kawasumi Laboratories Inc.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.11 Maco Pharma International GmbH
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.12 Mitra Industries Pvt. Ltd.
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.13 Neomedic Limited
- 16.3.13.1 Company Overview
- 16.3.13.2 Product Portfolio
- 16.3.14 Poly Medicure Ltd.
- 16.3.14.1 Company Overview
- 16.3.14.2 Product Portfolio
- 16.3.15 Span Healthcare Private Limited
- 16.3.15.1 Company Overview
- 16.3.15.2 Product Portfolio
- 16.3.16 Suru International Private Ltd.
- 16.3.16.1 Company Overview
- 16.3.16.2 Product Portfolio
- 16.3.17 Teleflex Incorporated
- 16.3.17.1 Company Overview
- 16.3.17.2 Product Portfolio
- 16.3.17.3 Financials
- 16.3.17.4 SWOT Analysis
- 16.3.18 Terumo Corporation
- 16.3.18.1 Company Overview
- 16.3.18.2 Product Portfolio
- 16.3.18.3 Financials
- 16.3.18.4 SWOT Analysis
- 16.3.19 The Metric Company
- 16.3.19.1 Company Overview
- 16.3.19.2 Product Portfolio
- 16.3.20 Troge Medical GmbH
- 16.3.20.1 Company Overview
- 16.3.20.2 Product Portfolio